SciSparc SPRC
NASDAQ SPRC
$6.50 -0.24 (-3.56%)
As of: Aug 21, 2026 · 10:11 AM EDT

SciSparc (SPRC) Finished Goods (2022 - 2025)

SciSparc (SPRC) posted Finished Goods of $58000.0 for Q4 2025, down 44.23% sequentially from $104000.0 in Q4 2024, and down 44.23% YoY from $104000.0 in Q4 2024.

SciSparc (SPRC) Finished Goods (2022 - 2025) Analysis & Trends

SciSparc has reported Finished Goods for 4 years, with the latest figure at $58000.0 in Q4 2025.

  • Quarterly Finished Goods fell 44.23% year-over-year to $58000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $58000.0 (down 44.23% YoY) and the FY2025 annual result came in at $58000.0, down 44.23% from the prior year.
  • Finished Goods eased to $58000.0 in Q4 2025 per SPRC's latest filing, from $104000.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $669000.0 in Q4 2023 and troughed at $58000.0 in Q4 2025.
  • A 4-year average of $325250.0 and a median of $287000.0 in 2022 frame the typical range for Finished Goods.
  • The sharpest annual moves came in 2023 and 2024: Finished Goods jumped 42.34% in 2023, then slumped 84.45% in 2024.
  • Over 4 years, Finished Goods stood at $470000.0 in 2022, then jumped by 42.34% to $669000.0 in 2023, then slumped by 84.45% to $104000.0 in 2024, then tumbled by 44.23% to $58000.0 in 2025.
  • According to Business Quant data, Finished Goods over the past three periods registered $58000.0, $104000.0, and $669000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.01 Bn 132.16 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn
4 Moderna 60.18 Bn 55.04 Bn 52.00 Mn
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.55 Bn 28.24 Bn 992.69 Mn
7 BioNTech SE 28.45 Bn 10.06 Bn 668.28 Mn
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn
9 Royalty Pharma 27.19 Bn 26.36 Bn -
10 SciSparc 807,202.50 807,202.50 -

Historic Data

Download Data
DateValue
Dec 31, 2025 58,000.00
Dec 31, 2024 104,000.00
Dec 31, 2023 669,000.00
Dec 31, 2022 470,000.00